[ORGANIZATION]
REDEFINE 1
Featured in 1 tracked story · first seen
Situations
Novo Nordisk CagriSema clinical trial results
2 clusters · 7 sources · last updated
Latest: Novo Nordisk experimental drug CagriSema shows 25% weight loss in women
Novo Nordisk has released findings from Phase 3 clinical trials regarding its experimental medication, CagriSema, which combines cagrilintide and semaglutide to treat diabetes and obesity. Initial results from the Phase